Baseline Fractional Flow Reserve and Stent Diameter Predict Optimal Post-Stent Fractional Flow Reserve and Major Adverse Cardiac Events After Bare-Metal Stent Deployment

JACC: Cardiovascular Interventions

Volumn 2, Issue 4, 2009, Pages 357-363

  Samady, Habib ^a   McDaniel, Michael ^a   Veledar, Emir ^a   De Bruyne, Bernard ^c   Pijls, Nico H ^b   Fearon, William F ^d   Vaccarino, Viola ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CATHARINA HOSPITAL   (Netherlands)

^c CARDIOVASCULAR CENTER   (Belgium)

^d STANFORD UNIVERSITY   (United States)

Author keywords

bare metal stents; fractional flow reserve; moderate coronary lesion assessment; percutaneous coronary interventions

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FRACTIONAL FLOW RESERVE; HEART DISEASE; HEART HEMODYNAMICS; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; REGISTER;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASIA; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; EUROPE; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; ODDS RATIO; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 64749111952     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.01.008     Document Type: Article

References (32)

1. Jaffe R., and Strauss B.H. Late and very late thrombosis of drug-eluting stents: evolving concepts and perspectives. J Am Coll Cardiol 50 (2007) 119-127
2. Camenzind E. Treatment of in-stent restenosis-back to the future?. N Engl J Med 355 (2006) 2149-2151
3. Curfman G.D., Morrissey S., Jarcho J.A., and Drazen J.M. Drug-eluting coronary stents-promise and uncertainty. N Engl J Med 356 (2007) 1059-1060
4. Beohar N., Davidson C.J., Kip K.E., et al. Outcomes and complications associated with off-label and untested use of drug-eluting stents. JAMA 297 (2007) 1992-2000
5. Holmes Jr. D.R., Kereiakes D.J., Laskey W.K., et al. Thrombosis and drug-eluting stents: an objective appraisal. J Am Coll Cardiol 50 (2007) 109-118
6. Lagerqvist B., James S.K., Stenestrand U., Lindback J., Nilsson T., and Wallentin L. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356 (2007) 1009-1019
7. Mauri L., Hsieh W.H., Massaro J.M., Ho K.K., D'Agostino R., and Cutlip D.E. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007) 1020-1029
8. Win H.K., Caldera A.E., Maresh K., et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 297 (2007) 2001-2009
9. Pijls N.H., Van Gelder B., Van der Voort P., et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 92 (1995) 3183-3193
10. Pijls N.H., van Son J.A., Kirkeeide R.L., De Bruyne B., and Gould K.L. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 87 (1993) 1354-1367
11. Bishop A.H., and Samady H. Fractional flow reserve: critical review of an important physiologic adjunct to angiography. Am Heart J 147 (2004) 792-802
12. Wentzel J.J., Krams R., Schuurbiers J.C., et al. Relationship between neointimal thickness and shear stress after Wallstent implantation in human coronary arteries. Circulation 103 (2001) 1740-1745
13. Bermejo J., Botas J., Garcia E., et al. Mechanisms of residual lumen stenosis after high-pressure stent implantation: a quantitative coronary angiography and intravascular ultrasound study. Circulation 98 (1998) 112-118
14. Fearon W.F., Luna J., Samady H., et al. Fractional flow reserve compared with intravascular ultrasound guidance for optimizing stent deployment. Circulation 104 (2001) 1917-1922
15. Hanekamp C.E., Koolen J.J., Pijls N.H., Michels H.R., and Bonnier H.J. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation 99 (1999) 1015-1021
16. Pijls N.H., Klauss V., Siebert U., et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 105 (2002) 2950-2954
17. Samady H., Ragosta M., and Beller G.A. Coronary collaterals, stenoses, and stents: is a new era of physiologic-guided percutaneous revascularization emerging?. J Am Coll Cardiol 40 (2002) 1551-1554
18. Jeremias A., Filardo S.D., Whitbourn R.J., et al. Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and pressure dynamics. Circulation 101 (2000) 318-323
19. van der Voort P.H., van Hagen E., Hendrix G., van Gelder B., Bech J.W., and Pijls N.H. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve. Cathet Cardiovasc Diagn 39 (1996) 120-125
20. Iakovou I., Mintz G.S., Dangas G., et al. Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries. Am J Cardiol 92 (2003) 1171-1176
21. Steinberg D.H., Mishra S., Javaid A., et al. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol 99 (2007) 599-602
22. Fischer J.J., Wang X.Q., Samady H., et al. Outcome of patients with acute coronary syndromes and moderate coronary lesions undergoing deferral of revascularization based on fractional flow reserve assessment. Catheter Cardiovasc Interv 68 (2006) 544-548
23. Oemrawsingh P.V., Mintz G.S., Schalij M.J., et al., TULIP Study Investigators. Intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 107 (2003) 62-67
24. Farb A., Burke A.P., Kolodgie F.D., and Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108 (2003) 1701-1706
25. Finn A.V., Joner M., Nakazawa G., et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 115 (2007) 2435-2441
26. Finn A.V., Nakazawa G., Joner M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007) 1500-1510
27. Joner M., Finn A.V., Farb A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006) 193-202
28. Nakazawa G., Finn A.V., and Virmani R. Vascular pathology of drug-eluting stents. Herz 32 (2007) 274-280
29. Schwartz R.S., Edelman E.R., Carter A., et al. Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group. Circulation 106 (2002) 1867-1873
30. Virmani R., Guagliumi G., Farb A., et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation 109 (2004) 701-705
31. Zahn R., Hamm C.W., Zeymer U., et al., deutsche Cyper-Register. Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry. Herz 29 (2004) 181-186
32. Biondi-Zoccai G.G., Sangiorgi G.M., Antoniucci D., et al., TRUE Study Investigators. Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE) Study. Int J Cardiol 117 (2007) 349-354